Katy Rezvani on the clinical trial she's leading
Dr. Katy Rezvani of MD Anderson talks with the American Cancer Society about the:\n\n1:30 \u2013 Biden Cancer Summit and Cancer Moonshot at MD Anderson. \n2:55 \u2013 Urgency and excitement in immunotherapy\n4:40 \u2013 On why she decided to go after natural killer cells instead of T cells\n8:13 \u2013 Could there really be an off-the-shelf CAR NK cell?\n9:12 \u2013 Three advantages of CAR NK cells\n13:26 \u2013 Clinical trial she\u2019s leading at MD Anderson \n15:00 \u2013 Crucial early support from ACS